Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fiona E. Braegger"'
Publikováno v:
Digestive Diseases. 38:466-473
Background: Our goal was to investigate the 3-year persistence rates with second-line vedolizumab and tumor necrosis factor-α (TNF-α) inhibitors (i.e., adalimumab, golimumab, infliximab) in patients with inflammatory bowel disease (IBD) who were fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0973a249e8e4fb68242916a2caeff05b
https://doi.org/10.1159/000506121
https://doi.org/10.1159/000506121
Autor:
Cristina Anna Gallelli, Carlo Cifani, Justyna Barbara Koczwara, Silvana Gaetani, Adele Romano, Thomas A. Lutz, Maria Vittoria Micioni Di Bonaventura, Mario Falchi, Tommaso Cassano, Fiona E. Braegger, Annabella Vitalone
Publikováno v:
Pharmacological Research. 122:20-34
The satiety-promoting action of oleoylethanolamide (OEA) has been associated to the indirect activation of selected brain areas, such as the nucleus of the solitary tract (NST) in the brainstem and the tuberomammillary (TMN) and paraventricular (PVN)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7554b7b381934c54712eac3fd4e6051f
https://doi.org/10.1016/j.phrs.2017.05.017
https://doi.org/10.1016/j.phrs.2017.05.017
Publikováno v:
European Journal of Neuroscience
Amylin reduces meal size by activating noradrenergic neurons in the area postrema (AP). Neurons in the AP also mediate the eating inhibitory effects of salmon calcitonin (sCT) a potent amylin agonist but the phenotypes of the neurons mediating its ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f89303fc480e11d0aed82b2751b2e29a
https://doi.org/10.1111/ejn.12672
https://doi.org/10.1111/ejn.12672